fda warning about compounded semaglutide issues some versions of for diabetes, weight loss compounded semaglutide discontinued Navigating changes

Apr 2016;28(5):648-54

They work with your body to regulate appetite, improve insulin sensitivity, and support fat loss in a way that feels more natural and sustainable

Darby Kozak is the Deputy Director for the Office of Generic Drugs (OGD) where he serves as a senior agency advisor in the development and implementation of FDA policies and long-range objectives for generic drug scientific programs and activities, including the development of a strategic plan for the Generic Drug Program

A STEP 1 subanalysis did show that participants taking 1 mg of semaglutide lost an average of roughly 16% of their body weight over 64 weeks, which was close to the results at 2.4 mg

However, experts cautioned that the findings are still preliminary